A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease (NCT07113522)
A Phase 2, Multi-Center, Platform Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics With Multiple Therapies in Participants With Active Crohn's Disease or Active Ulcerative Colitis (ASCEND-IBD)
🩺 Plain-English Summary (8th-Grade Level)
This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
Who can join: Review the eligibility criteria below.
Location: Mirador Therapeutics Selected Site — Birmingham, Alabama
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (66 Sites)
Showing the first 25 of 66 sites.
- Mirador Therapeutics Selected Site — Birmingham, Alabama
- Mirador Therapeutics Selected Site — Scottsdale, Arizona
- Mirador Therapeutics Selected Site — Sun City, Arizona
- Mirador Therapeutics Selected Site — Little Rock, Arkansas
- Mirador Therapeutics Selected Site — Little Rock, Arkansas
- Mirador Therapeutics Selected Site — Colorado Springs, Colorado
- Mirador Therapeutics Selected Site — Littleton, Colorado
- Mirador Therapeutics Selected Site — Miami, Florida
- Mirador Therapeutics Selected Site — Miami, Florida
- Mirador Therapeutics Selected Site — Miami, Florida
- Mirador Therapeutics Selected Site — Orlando, Florida
- Mirador Therapeutics Selected Site — Palmetto Bay, Florida
- Mirador Therapeutics Selected Site — Pensacola, Florida
- Mirador Therapeutics Selected Site — Atlanta, Georgia
- Mirador Therapeutics Selected Site — Snellville, Georgia
- Mirador Therapeutics Selected Site — Glenview, Illinois
- Mirador Therapeutics Selected Site — Gurnee, Illinois
- Mirador Therapeutics Selected Site — Lafayette, Louisiana
- Mirador Therapeutics Selected Site — Marrero, Louisiana
- Mirador Therapeutics Selected Site — Shreveport, Louisiana
- Mirador Therapeutics Selected Site — Ypsilanti, Michigan
- Mirador Therapeutics Selected Site — Bridgeton, Missouri
- Mirador Therapeutics Selected Site — Kansas City, Missouri
- Mirador Therapeutics Selected Site — Liberty, Missouri
- Mirador Therapeutics Selected Site — Las Vegas, Nevada
📞 Contact the Study Coordinator
Phone: (844) 206-4980
Email: clinicaltrials@miradortx.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Inflammatory Bowel Disease (IBD)
- Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease — Nashville, Tennessee
- Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease — Boston, Massachusetts
- VR Therapies for IBD — Los Angeles, California
- Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease — Boston, Massachusetts
- Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD) — Nashville, Tennessee
- Evaluation of the SMART IBD App in Pediatric IBD — Cincinnati, Ohio
Explore by condition: All Inflammatory Bowel Disease (IBD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.